Status:
COMPLETED
Human Blood Specimen Collection to Evaluate Immune Cell Function
Lead Sponsor:
Ottawa Hospital Research Institute
Collaborating Sponsors:
ATGen Canada Inc
Conditions:
Colorectal Cancer
Surgery
Eligibility:
All Genders
40+ years
Brief Summary
Natural killer (NK) cells are leukocytes of the innate immune system and play a central role in the control of cancer metastases. NK cells and other innate immune cells often do not function well in p...
Detailed Description
Rationale: The purpose of this program is to obtain consent for and to outline the process for collection of fresh blood sample from healthy humans and colorectal cancer patients before and after sur...
Eligibility Criteria
Inclusion
- Subjects who have had a recent diagnosis of cancer (any stage) and will be undergoing surgery (cancer group)
- Subjects who are being seen by their physician for other reasons, or healthy volunteers (control group)
- Subjects who provide informed consent to participate in the trial
- Subjects \>40 years of age
Exclusion
Key Trial Info
Start Date :
August 1 2016
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2018
Estimated Enrollment :
69 Patients enrolled
Trial Details
Trial ID
NCT03422120
Start Date
August 1 2016
End Date
October 1 2018
Last Update
January 15 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Ottawa Hospital
Ottawa, Ontario, Canada, K1H 8L6